< Back to previous page
Researcher
Séverine Vermeire
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 63
- Development of new strategies for value-based care in chronic inflammatory bowel diseases.From5 Dec 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Gut functional and inflammatory disorders: biomarker and therapeutic target discovery (GUT-FIRE)From10 Jul 2023 → TodayFunding: IOF - mandates
- Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesFrom1 Apr 2023 → TodayFunding: HORIZON.2.1 - Health
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesFrom15 Feb 2023 → TodayFunding: BOF - projects
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Development of a gut-on-a-chip model for pre-clinical testing of drugs for inflammatory bowel diseaseFrom12 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesFrom15 Jun 2022 → TodayFunding: BOF - various
- Host-microbe interaction in intestinal homeostasis: unravelling the mechanisms involved in the onset of multiple inflammationrelated diseasesFrom1 Jan 2022 → TodayFunding: FWO EOS
- Histological healing in inflammatory bowel diseaseFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
881 - 890 of 1016
- Role of genetics in prediction of disease course and response to therapy(2010)
Authors: Séverine Vermeire, Gert Van Assche, Paul Rutgeerts
Pages: 2609 - 2615 - Diagnostic and Therapeutic Approaches to Postoperative Recurrence in Crohn's Disease(2010)
Authors: Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Pages: 498 - 507 - Genetics of Inflammatory Bowel Disease: How Modern Genomics Informs Basic, Clinical and Translational Science(2010)
Authors: Séverine Vermeire, Gert Van Assche, Paul Rutgeerts
Pages: 16 - 24 - Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity(2010)
Authors: Séverine Vermeire, Paul Rutgeerts
Pages: 357 - 363 - Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)(2010)
Authors: Paul Rutgeerts, Séverine Vermeire
Pages: 292 - 294 - Postinfectious Irritable Bowel Syndrome: A Genetic Link Identified?(2010)
Authors: Séverine Vermeire, Gert Van Assche, Paul Rutgeerts
Pages: 1246 - 1249 - Immortal time bias and infliximab-related mortality and malignancy incidence Response(2010)
Authors: Kristel Van Steen, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire
Pages: 416 - 416 - Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy(2010)
Authors: Gert Van Assche, Séverine Vermeire, Ingrid Demedts, Raf Bisschops, Georges Coremans, Paul Rutgeerts
Pages: 320 - 324 - Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease(2010)
Authors: Gert Van Assche, Paul Rutgeerts, Séverine Vermeire
Pages: 463 - 468 - The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations(2010)
Authors: Gert Van Assche, Séverine Vermeire
Pages: 63 - 101
Patents
1 - 10 of 10
- Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis (Inventor)
- Predicting a treatment response in inflammatory bowel disease (Inventor)
- Predicting a treatment response in inflammatory bowel disease (Inventor)
- A new inflammation associated, low cell count enterotype (Inventor)
- Methods for predicting post-operative recurrence of crohn's disease (Inventor)
- Methods for predicting post-operative recurrence of crohn's disease (Inventor)
- A new inflammation associated, low cell count enterotype (Inventor)
- Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis (Inventor)
- Biomarker panel for assessment of mucosal healing (Inventor)
- METHODS FOR PREDICTING POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE (Inventor)